Seiji Mabuchi
Impact in
- Obstetrics and Gynecology top 0.2%
- Endometrial and Cervical Cancer Treatments
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Endometrial and Cervical Cancer Treatments 86
- Uterine Myomas and Treatments 19
-
- Ovarian cancer diagnosis and treatment 65
- Endometriosis Research and Treatment 18
- Co-authors
- Tadashi Kimura (80 shared papers)Hiromasa Kuroda (30 shared papers)Kenjiro Sawada (60 shared papers)Ryoko Takahashi (23 shared papers)Yuri Matsumoto (46 shared papers)Tadashi Kimura (43 shared papers)Kae Hashimoto (32 shared papers)Masahide Ohmichi (17 shared papers)
- Journals
- International Journal of Gynecological Cancer (21 papers)Gynecologic Oncology (13 papers)Cancer Research (9 papers)Oncotarget (7 papers)Clinical Cancer Research (6 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Seiji Mabuchi
184 papers receiving 5.6k citations
Seiji Mabuchi's Hit Papers
Peers
Comparison fields: 5 of 126
- Obstetrics and Gynecology 1.4k
- Reproductive Medicine 1.5k
- Cancer Research 1.1k
- Oncology 1.6k
- Immunology 959
Countries citing papers authored by Seiji Mabuchi
This map shows the geographic impact of Seiji Mabuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seiji Mabuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seiji Mabuchi more than expected).
Fields of papers citing papers by Seiji Mabuchi
This network shows the impact of papers produced by Seiji Mabuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seiji Mabuchi. The network helps show where Seiji Mabuchi may publish in the future.
Co-authors
The 25 scholars most cited alongside Seiji Mabuchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer Hit paper breakdown → | 2015 | 335 |
| 2 | 2007 | 202 | |
| 3 | 2004 | 185 | |
| 4 | 2016 | 183 | |
| 5 | 2007 | 156 | |
| 6 | 2002 | 146 | |
| 7 | 2009 | 131 | |
| 8 | 2015 | 124 | |
| 9 | 2004 | 118 | |
| 10 | 2018 | 110 | |
| 11 | 2014 | 104 | |
| 12 | 2004 | 100 | |
| 13 | 2016 | 95 | |
| 14 | 2020 | 86 | |
| 15 | 2017 | 86 | |
| 16 | 2016 | 85 | |
| 17 | 2013 | 84 | |
| 18 | 2011 | 82 | |
| 19 | 2006 | 79 | |
| 20 | 2012 | 77 |
About Seiji Mabuchi
Seiji Mabuchi is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Molecular Biology, Oncology and Surgery, having authored 192 papers that have together received 5.7k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (86 papers), Ovarian cancer diagnosis and treatment (65 papers), Cervical Cancer and HPV Research (22 papers), Colorectal and Anal Carcinomas (20 papers), Uterine Myomas and Treatments (19 papers), Endometriosis Research and Treatment (18 papers), Inflammatory Biomarkers in Disease Prognosis (16 papers) and Reproductive System and Pregnancy (16 papers). The work is most often cited by research in Obstetrics and Gynecology (1.4k citations), Reproductive Medicine (1.5k citations), Cancer Research (1.1k citations), Oncology (1.6k citations) and Immunology (959 citations). Seiji Mabuchi has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Tadashi Kimura, Hiromasa Kuroda, Kenjiro Sawada, Ryoko Takahashi, Yuri Matsumoto, Tadashi Kimura, Kae Hashimoto, Masahide Ohmichi, Tomoyuki Sasano and Hirohisa Kurachi. Their work appears in journals such as International Journal of Gynecological Cancer, Gynecologic Oncology, Cancer Research, Oncotarget and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.